NCT05746039: Feasibility of Semaglutide in Advanced Lung Disease
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 8 planned
- Started
- 29 Jan 2024
- Primary completion
- 28 Dec 2027
- Arms
- Study Drug (semaglutide)
- Results
- None posted
- 27 Feb 2023: Trial registered
- 29 Jan 2024: Trial started